NimbleHeart is now pleased to offer remote cardiac exercise screening service all over the US using Physiotrace Smart Cloud connected telemetry. Individuals who exercise at home or any gym and would like to understand the cardiac risk associated with their exercise can benefit from this. Please find more information on our Preventive Screening page.
NimbleHeart started a preventive cardiac screening program through monitored exercise testing for the individuals with cardiac risk. The screening is offered by clinical exercise physiologists or nurses either in-person or remotely to record your Exercise ECG, receive interpretation with full report, exercise guidance, heart’s functional capacity, cardiac risk factors and Physician referral. Please find more information on our Preventive Screening page
The patent office of Government of India has granted a patent named “Method and Apparatus for Motion Artifact reduction in ECG harness” to NimbleHeart. This helps NimbleHeart establish the uniqueness of the exercise ECG technology innovation and ability to help the cardiac risk population in India.
NimbleHeart was featured as one of the global innovators of Indian origin for our FDA cleared patented ambulatory outpatient wearable and reusable exercise ECG technology product published in this book. The book is available on Amazon in multiple countries.
NimbleHeart was a proud sponsor of the California Society of Cardiac Rehabilitation event at Stanford on May 12/13, where we conducted a live demo to demonstrating the wearable and cloud based Exercise ECG telemetry for different modalities of Cardiac rehabilitation.
The continuation of virtual or home based cardiac rehabilitation is getting support from the government through the introduction of a bi-partisan bill for sustainable home rehab act introduced in a timely manner in congress.
NimbleHeart’s CEO Sonal Tambe attended and supported the First Responders’ wellness conference at Tempe in Arizona to show our company’s support to the wellness and proactive preventive screening using easy tp wear and test exercise ECG technology for early detection of Cardiac anomalies in the men and women in uniform that save our lives.
NimbleHeart’s unmatched leading edge technology and the validated clinical use cases led it to be recognized at the top 5 finalist at Health Tech Pavilion of American Heart Association (AHA.org) Scientific Session 2022 at Chicago. Here is a video of the interview of Sonal Tambe, CEO of NimbleHeart at the conference recorded after her presentation.
Coverage by American Heart Association Here
Like its previous 4 years sponsorship and support to AACVPR organization including the Virtual conferences during Covid, NimbleHeart team joined a lively environment at in-person conference at Palm Beach in Florida. Our team did a live demonstration of the Exercise ECG telemetry that is FDA cleared and cloud supported to empower Virtual and Hybrid mode cardiac rehabilitation of post-procedure patients.
NimbleHeart Physiotrace Smart was chosen by Wellness Solutions, to perform preventive Cardiac screening of the men and women in uniform that help save our lives – First responders. A shocking percentage of them die of Cardiovascular events.
Physiotrace Smart with its dry-electrode based fully reusable technology and clinical grade exercise ECG signal is now emerging to be a convenient, easy-to-prepare and easy-to-use solution for routine screening of First Responders staff in a discrete and time efficient way.
USPTO granted NimbleHeart a patent for dry electrode-based ECG harness design. Even small movements like patient breathing can affect the patient skin contact with electrodes causing artifacts in ECG tracings. NimbleHeart harness system design overcomes this and achieves clinical grade outpatient exercise ECG for preventive care and cardiac screening
Established cardiac, intensive cardiac, and pulmonary rehab services (CR/ICR/PR) have the option of delivering virtual rehab sessions during the public health emergency (PHE). AACVPR recently learned that HHS has announced the Public Health Emergency (PHE) will likely remain in the place for the entirety of 2021. When a decision is made to terminate this declaration or let it expire, HHS will provide 60 days notice prior to termination.
Cardiology 2.0, an online Cardiology publication, in their special issue on Cardiac monitoring has recognized NimbleHeart as one of the leading companies that are changing the frontiers of Cardiac Monitoring. Here is the link to the published article in Cardiology 2.0 magazine covering the NimbleHeart story and highlighting the uniqueness of its product offering.
https://magazine.cardiology2.com/feb2020/nimbleheart_a_treadmill_test_in_a_wrap
During their latest technologies show aired on January 27th, 2020 on AMC channel, NewsWatch program covered NimbleHeart Physiotrace Smart with live exercise ECG demonstration on a male with no skin shaving or preparation.
This recent study indicates low patient participation in outpatient Cardiac Rehabilitation, especially by women and minority. NimbleHeart offers a discrete and reusable FDA cleared handsfree wearable exercise ECG monitor Physiotrace Smart to enable a true home based Cardiac rehab for such patients.
NimbleHeart was invited to exhibit at the first Space Health Innovations Conference (SHIC) held at the University of California, San Francisco. There was a great deal of interest for the products’ applications for the upcoming Space Tourism healthcare market. Specific interest was focused on performance, wear-ability, reusability, and the level of practical clinical significance.
NimbleHeart was a proud sponsor of the Innovative Delivery Model for Cardiac Rehabilitation exhibit at the Association of Cardiovascular and Pulmonary Rehabilitation’s (aacvpr.org) 34th Annual Conference held in Portland, OR. Home -based, “Hybrid” cardiac rehabilitation is the new frontier of preventive cardiac care. NimbleHeart has the unique technology to facilitate a true remotely monitored Exercise ECG for cardiac rehabilitation centers.
It is not surprising that the vision of remote cardiac care is becoming a reality! Evidence of this trend can be found in the following articles. With new reimbursement guidelines, CMS is also racing along with the new technologies to usher in a new era of preventive cardiac care.
Home-based heart rehab may help patients who can’t get to clinics
USPTO granted NimbleHeart a patent that uniquely identifies the technology to stream live clinical ECG data over Bluetooth Low Energy Interface.
It differentiates NimbleHeart’s technology capabilities from a plethora of ECG snapshot type devices as well as the Bluetooth capable Holter type devices on the market where the data is not displayed live while it is acquired.
NimbleHeart team headquarters in Silicon Valley moved to a new R&D and manufacturing capable facility at Miraloma Business Park in Sunnyvale.
NimbleHeart’s Physiotracetm Smart got FDA’s class II 510(k) clearance to market. The Physiotracetm Smart has a wearable and reusable design that can be wrapped and fastened around the torso. The device uses dry ECG electrodes and embeds an ECG acquisition unit with a Bluetooth Low Energy transmitter. A mobile application controls the data acquisition, displays the status of the device, heart rate and optionally the ECG waveform during a recording session. The mobile App also stores the ECG and the exercise session information and relays it to a cloud server for permanent storage and review by healthcare staff. The Physiotracetm Smart is designed to be used without electrolytic gels and without adhesives that necessitate skin preparation.
NimbleHeart Inc. is excited to announce that it has been selected as a “2016 TiE50 Winner” for the prestigious TiE50 Technology Awards Program. Winners were announced on Friday, May 6th at the organization’s annual entrepreneurial conference, TiEcon. TiEcon is the world’s largest conference for entrepreneurs and intrapreneurs with loyal participation from top technology companies, leading venture capital firms, and global service providers. Each year, about 5000 attendees from across the world converge upon the Silicon Valley to attend TiEcon.
Steven Keteyian, PhD. PhD, FAACVPR the director of Preventive Cardiology at Henry Ford Hospital in Michigan and the board member of American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) has accepted a role on NimbleHeart’s board of advisors.
NimbleHeart delivered second version of Male and Female ECG harnesses to NASA. The following patch was created by NASA AMES research center team to honor our partnership.
NimbleHeart’s pre-FDA harness was tested on 20 patients at 3 different sites of Henry Ford Hospital Cardiac Rehab program for wearability and patient acceptance.
The study was completed successfully and NimbleHeart received great patient feedback through the same.
“The biggest personal advantage I see is the lack of stickers to deal with. The NimbleHeart harness was faster and quicker to put on and take off. It treated this hairy guy with kid gloves !”
“I liked it so much better. It was not in the way and I didn’t have to contend with the glue from the electrodes that irritate my skin.”
“Can’t wait to replace the old system. (Its more practical and simple and comfortable than old unit by far.)”
Matthew Saval, MS, ACSM-RCEP performed a brief live demonstration of NimbleHeart’s innovative, clinical grade one lead dry electrode ECG harness during his presentation on “Integrating Technology into Cardiac Rehabilitation”, during the 62nd annual meeting of American College of Sports Medicine in San Diego, California.
NimbleHeart Cofounder and Chief Medical Officer, Dr. Pramod Deshmukh presented NimbleHeart’s technology and innovative solution during 2015 Stanford Biodesign New Arrhythmia Technologies Retreat.
Successfully completed the design of and delivered 12 lead dry electrode based ECG harnesses to NASA. They were tested on male and female subjects to produce clinical grade ECG during supine position, steady state vertical position and during physical exercises such as treadmill walk and biking. These harnesses will be used in the space flight for monitoring of crew members for health, performance and safety.
Clinical study was performed in India with 25 patients with a goal to validate the dry electrode harness based ambulatory ECG technology.
12 lead ECG treadmill test was compared against NimbleHeart’s single channel modified CB5 lead proof of concept hardware. NimbleHeart device showed comparable ECG results with ST segment changes in the patients.
© 2017 nimbleheart.com